Creative Biolabs, a biotechnology service provider specializing in immuno-oncology research, has announced an exclusive webinar titled "Modeling T Cell Dysfunction in Tumor Microenvironments." The live virtual event is scheduled for September 1, 2026, at 10:00 AM EDT, and will feature keynote speaker Greg M. Delgoffe, Ph.D., Professor of Immunology at the University of Pittsburgh and Director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center.
The webinar addresses a critical challenge in oncology: the tumor microenvironment (TME) and its role in T cell dysfunction. As tumors progress, they create a metabolically hostile environment characterized by nutrient depletion and accumulation of immunosuppressive byproducts. These metabolic pressures impair immune cell function, leading to T cell exhaustion, immune evasion, and reduced efficacy of immunotherapies. Understanding these mechanisms is essential for developing more effective cancer treatments.
Traditional preclinical models often fail to capture the complex interactions between tumor metabolism and immune regulation. Dr. Delgoffe's presentation will focus on innovative approaches to modeling these conditions, utilizing advanced in vivo and in vitro systems that replicate metabolic stress. By leveraging advanced preclinical testing services, researchers can better investigate immune suppression and therapeutic responses under physiologically relevant conditions, improving the translational value of their studies.
Key webinar highlights include understanding how tumor metabolic environments contribute to immune suppression and T cell exhaustion, strategies for modeling TME conditions in preclinical research, the mechanisms underlying T cell dysfunction influenced by nutrient depletion, and how immunometabolism insights can guide therapeutic strategies to enhance cancer immunotherapy.
This webinar is particularly relevant for cancer immunology researchers, pharmaceutical and biotechnology professionals, and R&D teams focused on oncology drug discovery. It offers an opportunity to gain insights from a leading expert in the field and to explore how advanced modeling approaches can be applied to target discovery and validation.
The event underscores the growing importance of understanding the TME in developing next-generation immunotherapies. By addressing the metabolic barriers that impede T cell function, researchers can identify new avenues for intervention and improve patient outcomes.
For webinar details and registration, visit https://www.creative-biolabs.com/immuno-oncology/webinar-modeling-t-cell-dysfunction-tumor-microenvironments.htm.
